Search results for "LONG"

showing 10 items of 3969 documents

Behavioural parameters in aged rats are related to LTP and gene expression of ChAT and NMDA-NR2 subunits in the striatum.

2004

Striatal parameters were assessed for their relevance to age-related behavioural decline. Forty aged rats (28-30 months) were tested in the water maze and open field. Of these, seven superior and seven inferior learners were compared with each other in terms of levels of in vitro short- and long-term potentiation (STP and LTP), and gene expression of choline acetyltransferase (ChAT) as well as of the NMDA-NR2A-C subunits assessed by quantitative RT-PCR. Results revealed that the superior as compared with the inferior learners had higher levels of ChAT mRNA in the striatum. For the superior group, ChAT mRNA was correlated with escape on to the cued platform in the water maze, whereas level o…

Malemedicine.medical_specialtyAgingeducationLong-Term PotentiationStriatumWater mazeReceptors N-Methyl-D-AspartateOpen fieldCholine O-AcetyltransferaseInternal medicineGene expressionmedicineAnimalsRNA MessengerRats WistarMaze LearningGeneral NeuroscienceLong-term potentiationCholine acetyltransferaseCorpus StriatumRatsEndocrinologynervous systemGene Expression RegulationSynaptic plasticityExploratory BehaviorNMDA receptorPsychologyNeuroscienceThe European journal of neuroscience
researchProduct

P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).

2011

Long-term risk prediction is a priority for the prevention of atrial fibrillation (AF). P wave indices are electrocardiographic measurements describing atrial conduction. The role of P wave indices in the prospective determination of AF and mortality risk has had limited assessment. We quantified by digital caliper the P wave indices of maximum duration and dispersion in 1,550 Framingham Heart Study participants ≥ 60 years old (58% women) from single-channel electrocardiograms recorded from 1968 through 1971. We examined the association of selected P wave indices and long-term outcomes using Cox proportional hazards regression incorporating age, gender, body mass index, systolic blood press…

Malemedicine.medical_specialtyArticleElectrocardiographyFramingham Heart StudyPredictive Value of TestsRisk FactorsInternal medicineAtrial FibrillationMedicineHumansLongitudinal StudiesPR intervalRisk factorAgedProportional Hazards Modelsbusiness.industryProportional hazards modelIncidenceHazard ratioAtrial fibrillationMiddle Agedmedicine.diseaseConfidence intervalUnited StatesPhenotypeHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American journal of cardiology
researchProduct

Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics.

2006

Abstract Objectives The larger number of bifidobacteria in the intestine of breast-fed infants has been associated with their better health compared with formula-fed infants. We assessed the safety and tolerability of an experimental formula containing 2 × 10 7 colony-forming units of Bifidobacterium longum BL999 and 4 g/L of a prebiotic mixture containing 90% galacto-oligosaccharides and 10% fructo-oligosaccharides. Methods A 7-mo prospective, randomized, reference-controlled, double-blinded trial was performed in infants who were not breast fed after the 14th day of birth. One hundred thirty-eight infants were enrolled and assigned to receive the control or experimental formula until they…

Malemedicine.medical_specialtyBifidobacterium longumEndocrinology Diabetes and Metabolismmedicine.medical_treatmentColony Count MicrobialOligosaccharidesBiologyWeight GainGastroenterologylaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineHumansFood scienceProspective StudiesProspective cohort studyAdverse effectInfant Nutritional Physiological PhenomenaRespiratory Tract InfectionsNutrition and DieteticsPrebioticProbioticsInfant NewbornInfantbiology.organism_classificationBody HeightInfant FormulaIntestinesInfant formulaTolerabilityConsumer Product SafetyFemaleBifidobacteriummedicine.symptomWeight gainConstipationHeadNutrition (Burbank, Los Angeles County, Calif.)
researchProduct

Ipsilateral facial weakness in upper medullary infarction-supranuclear or infranuclear origin?

1999

We describe two patients with upper medullary infarctions showing ipsilateral facial weakness and relative sparing of the upper facial muscles. Electrophysiological follow-up using transcranial magnetic stimulation of the motor cortex in combination with stimulation of the peripheral facial nerve disclosed a supranuclear (corticofacial) tract lesion in one patient and a partial nuclear/infranuclear intra-axial facial nerve lesion in another.

Malemedicine.medical_specialtyBrain Stem InfarctionsMedullary cavitymedicine.medical_treatmentFacial MusclesLesionReflexmedicineHumansAgedParesisMedulla OblongataMuscle Weaknessbusiness.industryMotor CortexFacial weaknessAnatomyMiddle AgedMagnetic Resonance ImagingFacial nerveElectric StimulationSurgeryTranscranial magnetic stimulationFacial Nervestomatognathic diseasesFacial musclesmedicine.anatomical_structureNeurologyNeurology (clinical)medicine.symptombusinessMotor cortexJournal of Neurology
researchProduct

Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation

2013

ObjectivesThis study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE]).BackgroundRisk stratification after TAVI remains challenging. The use of biomarkers in this setting represents an unmet need.MethodsCA125 was measured in 228 patients before and after TAVI. The association with outcomes was assessed using parametric Cox regression and joint modeling for baseline and longitudinal analyses, respectively. CA125 was evaluated as logarithm transforma…

Malemedicine.medical_specialtyCardiac CatheterizationTime FactorsAortic Valve InsufficiencyMyocardial InfarctionKaplan-Meier EstimateRisk AssessmentCA125Interquartile rangeRisk FactorsInternal medicineMedicineHumansMyocardial infarctionLongitudinal StudiesRegistriesStroketranscatheter aortic valve implantationTumor markerAgedProportional Hazards ModelsAged 80 and overHeart FailureHeart Valve Prosthesis ImplantationProportional hazards modelbusiness.industryMembrane ProteinsAortic Valve Stenosismedicine.diseasejoint modelingHospitalizationStrokeLogistic ModelsTreatment OutcomeCardiovascular DiseasesHeart failureCA-125 AntigenMultivariate AnalysisCardiologybiomarkerBiomarker (medicine)FemaleprognosisbusinessCardiology and Cardiovascular MedicineMaceBiomarkersJACC: Cardiovascular Interventions
researchProduct

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder

1994

3-Hydroxyacyl-CoA dehydrogenase deficiency is a newly recognised fatty acid oxidation disorder with a usually fatal outcome. We present a further patient who presented with hypoketotic hypoglycaemia, hepatopathy, secondary carnitine deficiency and increased plasma long-chain acylcarnitines. 3-Hydroxydicarboxylic aciduria was present and the diagnosis confirmed in cultured skin fibroblasts. Our patient is compared with those reported in the literature with respect to clinical symptoms, differential diagnosis and possible therapeutic regimens.

Malemedicine.medical_specialtyCardiomyopathyLipid Metabolism Inborn ErrorsFatal OutcomeInternal medicineCarnitineMedicineHumansBeta oxidationchemistry.chemical_classificationCultured skinbusiness.industryLiver DiseasesInfant Newborn3-Hydroxyacyl CoA DehydrogenasesMitochondrial MyopathiesClinical Enzyme Testsmedicine.diseaseDehydrogenase deficiencyHypoglycemiaEnzymeEndocrinologychemistrySecondary carnitine deficiencyPediatrics Perinatology and Child HealthDifferential diagnosisbusinessCardiomyopathiesLong-Chain-3-Hydroxyacyl-CoA DehydrogenaseEuropean journal of pediatrics
researchProduct

Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain

2020

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are an established model of care designed to improve risk factor management. They have been successfully implemented in a variety of settings, in patients with coronary heart disease (CHD). Objective: To assess the long term impact of a nurse-coordinated, multidisciplinary, CVPRP in patients with CHD in the reduction of lipid profile and medication prescription in clinical practice. Methods: The study used an analytical, experimental, population based, prospective and longitudinal design. In Spain, the study was conducted in the Valencian Community, including two randomized hospitals. Coronary patients were prospec…

Malemedicine.medical_specialtyCardiotonic AgentsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentNurse's RoleMedication prescriptionCardiovascular preventionIntervention (counseling)HumansImmunology and AllergyMedicineLongitudinal StudiesProspective StudiesMedical prescriptionHealth policyAgedRehabilitationmedicine.diagnostic_testbusiness.industryMiddle AgedLipidsCoronary heart diseaseEuropePrimary PreventionCardiovascular DiseasesSpainEmergency medicineFemaleDiet HealthyHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessLipid profileRisk Reduction BehaviorEndocrine, Metabolic & Immune Disorders - Drug Targets
researchProduct

Optic Nerve Decompression Improves Hemodynamic Parameters in Papilledema

1993

Purpose: The purpose of this study is to examine changes in color Doppler imaging parameters before and after optic nerve sheath decompression (ONSD) for chronic papilledema caused by pseudotumor cerebri (PTC). Methods: Color Doppler imaging was performed within 48 hours before surgery and within 48 hours after the procedure using a color Doppler unit with a 7.5-MHz phased linear transducer. Pulsed Doppler spectrum analyses were recorded digitally on videotape from the ophthalmic, central retinal, and short posterior ciliary arteries, using a 0.4 × 0.6-mm sample volume. Results: Blood flow velocities in the ophthalmic, short posterior ciliary, and central retinal arteries of 24 eyes were si…

Malemedicine.medical_specialtyCentral retinal arteryVisual acuitygenetic structuresRetinal ArteryPseudotumor cerebriVisual AcuityOphthalmic Arterychemistry.chemical_compoundmedicine.arteryOphthalmologymedicineHumansLongitudinal StudiesPapilledemaUltrasonographyPseudotumor Cerebribusiness.industryCiliary BodyHemodynamicsOptic NerveRetinalArteriesShort posterior ciliary arteriesmedicine.diseaseeye diseasesSurgeryOphthalmologychemistryOphthalmic arteryChronic DiseaseOptic nerveFemalemedicine.symptombusinessBlood Flow VelocityFollow-Up StudiesPapilledemaOphthalmology
researchProduct

Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the 'accordion' regimen?

2007

The on-treatment virological response to pegylated interferon plus ribavirin therapy is a useful tool in the management of patients with chronic hepatitis C. The time at which hepatitis C virus RNA becomes undetectable by a sensitive PCR assay has a huge impact on the probability of achieving a sustained virological response, particularly in genotype 1 patients, and may be useful in selecting patients for prolonged therapy. Indiscriminate extension of treatment in patients with hepatitis C virus genotype 1 is not beneficial. However, there is a subgroup of patients – the so-called ‘slow responders’ – who benefit from extending treatment from 48 to 72 weeks and can be readily identified afte…

Malemedicine.medical_specialtyCombination therapyGenotypeHepatitis C virusHepacivirusProlonged therapyHepacivirusInterferon alpha-2Chronic hepatitis Cmedicine.disease_causeGastroenterologyAntiviral AgentsDrug Administration SchedulePolyethylene Glycolschemistry.chemical_compoundInterferonPegylated interferonInternal medicineRibavirinmedicineHumansCombination therapyPeginterferonRapid virological responseViral kineticsExtended treatmentHepatologybiologybusiness.industryRibavirinPatient SelectionInterferon-alphaHepatitis C Chronicbiology.organism_classificationRecombinant ProteinsRegimenchemistryImmunologyRNA ViralDrug Therapy CombinationFemalebusinessPegylated interferonPeginterferon alfa-2amedicine.drugJournal of hepatology
researchProduct

Osteogenesis imperfecta: a clinical study of the first ten years of life.

1992

One hundred twenty-seven children with osteogenesis imperfecta (O.I.) were studied during the first 10 years of life. According to Sillence, 40 patients were assigned to type I, 39 to type III, and 48 to type IV O.I. Centiles for height, weight, and the annual number of fractures could be established for the different types of O.I. The development of the skeletal changes could be documented for the different forms of the disease. At birth, the skeletal changes were significantly more severe in type III than in type IV patients. During the first 10 years of life the number of fractures, extent of skeletal deformities, and growth retardation did not differ between types III and IV. Only fract…

Malemedicine.medical_specialtyDentinogenesis imperfectaEndocrinology Diabetes and MetabolismPoison controlShort statureBone and BonesClinical studyFractures BoneEndocrinologymedicineHumansOrthopedics and Sports MedicineLongitudinal StudiesInsulin-Like Growth Factor IChildHemihypertrophyBone Developmentbusiness.industryBody WeightInfant NewbornInfantOsteogenesis Imperfectamedicine.diseaseBody HeightSurgeryRadiographyScoliosisOsteogenesis imperfectaMotor SkillsChild PreschoolOrthopedic surgeryKidney stonesFemalemedicine.symptombusinessCalcified tissue international
researchProduct